| MP term | FDR (all) | IC level | SDMP level | Annotation (direct or inherited) |
Mammalian Phenotype (MP) | abnormal total tissue mass | 0.0000001736 | 1.188 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal body weight | 0.0000003144 | 1.156 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal CD8-positive, alpha-beta T cell number | 0.0000004594 | 1.758 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal CD4-positive, alpha beta T cell number | 0.000001471 | 1.7 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal platelet aggregation | 0.000005424 | 1.7 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal platelet activation | 0.000006839 | 1.7 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal blood homeostasis | 0.00001046 | 0.6893 | -- | DIRECT |
Mammalian Phenotype (MP) | thick skin | 0.00001389 | 2.603 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal T cell number | 0.00001579 | 1.261 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal postnatal growth/weight/body size | 0.00001921 | 0.8956 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal immune system morphology | 0.00002817 | 0.7223 | -- | DIRECT |
Mammalian Phenotype (MP) | decreased lymphocyte cell number | 0.0000382 | 1.156 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal lung weight | 0.00005558 | 2.302 | -- | DIRECT |
Mammalian Phenotype (MP) | small thymus | 0.0001115 | 2.126 | -- | DIRECT |
Mammalian Phenotype (MP) | decreased liver weight | 0.0001262 | 2.603 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal adipose tissue morphology | 0.0001473 | 1.223 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal hematopoietic system morphology/development | 0.000156 | 0.6686 | -- | DIRECT |
Mammalian Phenotype (MP) | embryonic lethality | 0.0001639 | 1.126 | -- | DIRECT |
Mammalian Phenotype (MP) | decreased leukocyte cell number | 0.0001955 | 1.156 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal muscle contractility | 0.000275 | 1.427 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal lymphocyte morphology | 0.0003334 | 0.9404 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal intestinal epithelium morphology | 0.0003927 | 1.758 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal liver size | 0.0004156 | 1.758 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal circulating cholesterol level | 0.0005029 | 1.524 | -- | DIRECT |
Mammalian Phenotype (MP) | increased tumor incidence | 0.0005114 | 1.172 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal lymphocyte physiology | 0.0005283 | 1.112 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal phagocyte morphology | 0.0007278 | 1.281 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal gland morphology | 0.0007579 | 0.7519 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal cholesterol level | 0.0007704 | 1.524 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal tumor incidence | 0.001008 | 1.141 | -- | INHERITED FROM: increased tumor incidence |
Mammalian Phenotype (MP) | altered tumor susceptibility | 0.0011 | 1.141 | -- | INHERITED FROM: increased tumor incidence |
Mammalian Phenotype (MP) | abnormal mononuclear cell morphology | 0.001214 | 0.8473 | -- | INHERITED FROM: abnormal CD8-positive, alpha-beta T cell number || abnormal T cell morphology || abnormal lymphocyte morphology || abnormal T cell number || abnormal CD4-positive, alpha beta T cell morphology || abnormal CD4-positive, alpha beta T cell number || abnormal lymphocyte cell number || abnormal CD8-positive, alpha beta T cell morphology || decreased lymphocyte cell number |
Mammalian Phenotype (MP) | abnormal renal corpuscle morphology | 0.001322 | 1.427 | -- | INHERITED FROM: abnormal renal glomerulus morphology |
Mammalian Phenotype (MP) | homeostasis/metabolism phenotype | 0.001348 | 0.3626 | -- | INHERITED FROM: impaired glucose tolerance || abnormal sterol level || abnormal homeostasis || abnormal blood coagulation || abnormal cholesterol homeostasis || abnormal glycogen level || abnormal platelet aggregation || abnormal cholesterol level || abnormal circulating cholesterol level || abnormal blood homeostasis || abnormal platelet activation |
Mammalian Phenotype (MP) | abnormal leukocyte cell number | 0.001409 | 0.9129 | -- | INHERITED FROM: abnormal CD8-positive, alpha-beta T cell number || decreased leukocyte cell number || abnormal T cell number || abnormal CD4-positive, alpha beta T cell number || abnormal lymphocyte cell number || decreased lymphocyte cell number || abnormal neutrophil cell number |
Mammalian Phenotype (MP) | abnormal platelet physiology | 0.001479 | 1.7 | -- | INHERITED FROM: abnormal platelet activation || abnormal platelet aggregation |
Mammalian Phenotype (MP) | abnormal hepatobiliary system morphology | 0.003653 | 1.098 | -- | INHERITED FROM: abnormal liver size || decreased liver weight |
Mammalian Phenotype (MP) | abnormal kidney morphology | 0.00535 | 1.156 | -- | INHERITED FROM: abnormal renal glomerulus morphology |
Mammalian Phenotype (MP) | abnormal glucose homeostasis | 0.008054 | 1.261 | -- | INHERITED FROM: abnormal glycogen level || impaired glucose tolerance |
Mammalian Phenotype (MP) | abnormal glycogen homeostasis | 0.009522 | 2.126 | -- | INHERITED FROM: abnormal glycogen level |
Mammalian Phenotype (MP) | integument phenotype | 0.01029 | 0.797 | -- | INHERITED FROM: thick skin |
Mammalian Phenotype (MP) | abnormal lipid level | 0.01221 | 1.156 | -- | INHERITED FROM: abnormal circulating cholesterol level || abnormal sterol level || abnormal cholesterol level |
Mammalian Phenotype (MP) | abnormal cell proliferation | 0.01473 | 1.324 | -- | INHERITED FROM: decreased cell proliferation |
Mammalian Phenotype (MP) | preweaning lethality | 0.01603 | 0.7055 | -- | INHERITED FROM: embryonic lethality || embryonic lethality prior to organogenesis |
Mammalian Phenotype (MP) | abnormal neutrophil morphology | 0.01645 | 1.904 | -- | INHERITED FROM: abnormal neutrophil cell number |
Mammalian Phenotype (MP) | renal/urinary system phenotype | 0.01981 | 0.931 | -- | INHERITED FROM: abnormal renal glomerulus morphology |
Mammalian Phenotype (MP) | abnormal hemostasis | 0.02141 | 1.399 | -- | INHERITED FROM: abnormal platelet activation || abnormal platelet aggregation || abnormal blood coagulation |
Mammalian Phenotype (MP) | embryonic lethality prior to tooth bud stage | 0.03051 | 1.457 | -- | INHERITED FROM: embryonic lethality prior to organogenesis |
Mammalian Phenotype (MP) | abnormal granulocyte number | 0.03054 | 1.758 | -- | INHERITED FROM: abnormal neutrophil cell number |
Mammalian Phenotype (MP) | abnormal prenatal growth/weight/body size | 0.03195 | 1.348 | -- | INHERITED FROM: abnormal embryonic growth/weight/body size |
Mammalian Phenotype (MP) | abnormal B cell physiology | 0.03246 | 1.172 | -- | INHERITED FROM: decreased B cell proliferation |
Mammalian Phenotype (MP) | abnormal hematopoietic system physiology | 0.03945 | 0.8789 | -- | INHERITED FROM: abnormal platelet activation || abnormal platelet aggregation || abnormal lymphocyte physiology || decreased B cell proliferation |
Mammalian Phenotype (MP) | muscle phenotype | 0.0447 | 0.8473 | -- | INHERITED FROM: abnormal muscle contractility |
Mammalian Phenotype (MP) | abnormal myeloid leukocyte morphology | 0.06945 | 1.223 | -- | INHERITED FROM: abnormal neutrophil cell number || abnormal phagocyte morphology |
Mammalian Phenotype (MP) | abnormal postnatal growth | 0.07025 | 1.524 | -- | INHERITED FROM: postnatal growth retardation |
Mammalian Phenotype (MP) | abnormal kidney cortex morphology | 0.07178 | 1.399 | -- | INHERITED FROM: abnormal renal glomerulus morphology |
Mammalian Phenotype (MP) | abnormal skin condition | 0.07358 | 2.302 | -- | INHERITED FROM: thick skin |
Mammalian Phenotype (MP) | digestive/alimentary phenotype | 0.107 | 0.9404 | -- | INHERITED FROM: abnormal intestinal epithelium morphology |
Mammalian Phenotype (MP) | abnormal B cell activation | 0.1498 | 1.562 | -- | INHERITED FROM: decreased B cell proliferation |
Mammalian Phenotype (MP) | abnormal effector T cell morphology | 0.1645 | 1.399 | -- | INHERITED FROM: abnormal CD8-positive, alpha beta T cell morphology || abnormal CD4-positive, alpha beta T cell number || abnormal CD4-positive, alpha beta T cell morphology || abnormal CD8-positive, alpha-beta T cell number |
Mammalian Phenotype (MP) | abnormal nephron morphology | 0.1661 | 1.261 | -- | INHERITED FROM: abnormal renal glomerulus morphology |
Mammalian Phenotype (MP) | abnormal circulating lipid level | 0.1823 | 1.241 | -- | INHERITED FROM: abnormal circulating cholesterol level |
Mammalian Phenotype (MP) | abnormal leukocyte morphology | 0.1912 | 0.8108 | -- | INHERITED FROM: abnormal T cell number || abnormal T cell morphology || abnormal CD8-positive, alpha-beta T cell number || decreased leukocyte cell number || abnormal lymphocyte morphology || decreased lymphocyte cell number || abnormal neutrophil cell number || abnormal CD4-positive, alpha beta T cell number || abnormal phagocyte morphology || abnormal lymphocyte cell number || abnormal CD4-positive, alpha beta T cell morphology || abnormal CD8-positive, alpha beta T cell morphology |
Mammalian Phenotype (MP) | abnormal immune cell physiology | 0.2107 | 0.9219 | -- | INHERITED FROM: abnormal lymphocyte physiology || decreased B cell proliferation |
Mammalian Phenotype (MP) | abnormal cell-mediated immunity | 0.2175 | 0.9219 | -- | INHERITED FROM: decreased B cell proliferation || abnormal lymphocyte physiology |
Mammalian Phenotype (MP) | abnormal hematopoietic cell number | 0.2182 | 0.8473 | -- | INHERITED FROM: abnormal CD4-positive, alpha beta T cell number || abnormal lymphocyte cell number || decreased lymphocyte cell number || abnormal neutrophil cell number || abnormal CD8-positive, alpha-beta T cell number || decreased hematopoietic cell number || decreased leukocyte cell number || abnormal T cell number |
Mammalian Phenotype (MP) | abnormal respiratory system morphology | 0.2201 | 1.072 | -- | INHERITED FROM: abnormal lung weight |
Mammalian Phenotype (MP) | abnormal adaptive immunity | 0.2328 | 0.9219 | -- | INHERITED FROM: decreased B cell proliferation || abnormal lymphocyte physiology |
Mammalian Phenotype (MP) | abnormal alpha-beta T cell morphology | 0.2349 | 1.373 | -- | INHERITED FROM: abnormal CD8-positive, alpha beta T cell morphology || abnormal CD4-positive, alpha beta T cell morphology || abnormal CD8-positive, alpha-beta T cell number || abnormal CD4-positive, alpha beta T cell number |
Mammalian Phenotype (MP) | abnormal immune system physiology | 0.2644 | 0.6789 | -- | INHERITED FROM: decreased B cell proliferation || abnormal lymphocyte physiology |
Mammalian Phenotype (MP) | abnormal liver weight | 0.2667 | 2.603 | -- | INHERITED FROM: decreased liver weight |
Mammalian Phenotype (MP) | abnormal lung morphology | 0.3335 | 1.205 | -- | INHERITED FROM: abnormal lung weight |
Mammalian Phenotype (MP) | abnormal glucose tolerance | 0.3929 | 1.825 | -- | INHERITED FROM: impaired glucose tolerance |
Mammalian Phenotype (MP) | abnormal cell physiology | 0.3973 | 0.6209 | -- | INHERITED FROM: decreased cell proliferation |
Mammalian Phenotype (MP) | abnormal survival | 0.6078 | 0.6441 | -- | INHERITED FROM: embryonic lethality prior to organogenesis || premature death || embryonic lethality |
Mammalian Phenotype (MP) | abnormal blood cell physiology | 0.6911 | 0.8789 | -- | INHERITED FROM: decreased B cell proliferation || abnormal lymphocyte physiology || abnormal platelet aggregation || abnormal platelet activation |
Mammalian Phenotype (MP) | abnormal liver morphology | 0.7133 | 1.156 | -- | INHERITED FROM: decreased liver weight || abnormal liver size |
Mammalian Phenotype (MP) | abnormal hematopoietic cell morphology | 0.7736 | 0.7167 | -- | INHERITED FROM: abnormal lymphocyte cell number || abnormal CD4-positive, alpha beta T cell number || abnormal neutrophil cell number || decreased lymphocyte cell number || abnormal T cell morphology || decreased leukocyte cell number || abnormal CD8-positive, alpha-beta T cell number || abnormal phagocyte morphology || abnormal CD4-positive, alpha beta T cell morphology || abnormal CD8-positive, alpha beta T cell morphology || decreased hematopoietic cell number || abnormal lymphocyte morphology || abnormal T cell number |
Mammalian Phenotype (MP) | abnormal immune system cell morphology | 0.7845 | 0.8038 | -- | INHERITED FROM: abnormal T cell morphology || decreased leukocyte cell number || abnormal CD8-positive, alpha-beta T cell number || abnormal lymphocyte morphology || abnormal T cell number || abnormal lymphocyte cell number || abnormal phagocyte morphology || abnormal CD4-positive, alpha beta T cell number || abnormal CD4-positive, alpha beta T cell morphology || abnormal CD8-positive, alpha beta T cell morphology || abnormal neutrophil cell number || decreased lymphocyte cell number |
Mammalian Phenotype (MP) | growth/size/body region phenotype | 0.0003147 | 0.6254 | Least Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal homeostasis | 0.0003433 | 0.4926 | Least Informative | DIRECT |
Mammalian Phenotype (MP) | hematopoietic system phenotype | 0.0005604 | 0.5945 | Least Informative | DIRECT |
Mammalian Phenotype (MP) | immune system phenotype | 0.0006742 | 0.5462 | Least Informative | DIRECT |
Mammalian Phenotype (MP) | cellular phenotype | 0.001349 | 0.5387 | Least Informative | INHERITED FROM: decreased cell proliferation |
Mammalian Phenotype (MP) | endocrine/exocrine gland phenotype | 0.001358 | 0.6947 | Least Informative | INHERITED FROM: abnormal gland morphology || small thymus |
Mammalian Phenotype (MP) | mortality/aging | 0.01705 | 0.5424 | Least Informative | INHERITED FROM: embryonic lethality || embryonic lethality prior to organogenesis || premature death |
Mammalian Phenotype (MP) | abnormal body composition | 0.0000005492 | 1.112 | Moderately Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal body size | 0.00000501 | 1.001 | Moderately Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal T cell morphology | 0.00002984 | 1.205 | Moderately Informative | DIRECT |
Mammalian Phenotype (MP) | adipose tissue phenotype | 0.0001695 | 1.205 | Moderately Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal lymphocyte cell number | 0.0001884 | 1.023 | Moderately Informative | DIRECT |
Mammalian Phenotype (MP) | decreased hematopoietic cell number | 0.0006151 | 1.072 | Moderately Informative | DIRECT |
Mammalian Phenotype (MP) | neoplasm | 0.001834 | 1.035 | Moderately Informative | INHERITED FROM: increased tumor incidence |
Mammalian Phenotype (MP) | liver/biliary system phenotype | 0.006273 | 1.012 | Moderately Informative | INHERITED FROM: decreased liver weight || abnormal liver size |
Mammalian Phenotype (MP) | abnormal renal/urinary system morphology | 0.007595 | 1.047 | Moderately Informative | INHERITED FROM: abnormal renal glomerulus morphology |
Mammalian Phenotype (MP) | abnormal endocrine gland morphology | 0.008117 | 1.141 | Moderately Informative | INHERITED FROM: small thymus |
Mammalian Phenotype (MP) | prenatal lethality | 0.00854 | 0.9129 | Moderately Informative | INHERITED FROM: embryonic lethality prior to organogenesis || embryonic lethality |
Mammalian Phenotype (MP) | abnormal muscle physiology | 0.01029 | 1.085 | Moderately Informative | INHERITED FROM: abnormal muscle contractility |
Mammalian Phenotype (MP) | respiratory system phenotype | 0.04179 | 0.9404 | Moderately Informative | INHERITED FROM: abnormal lung weight |
Mammalian Phenotype (MP) | abnormal immune system organ morphology | 0.05514 | 1.112 | Moderately Informative | INHERITED FROM: small thymus |
Mammalian Phenotype (MP) | abnormal digestive system morphology | 0.05522 | 1.023 | Moderately Informative | INHERITED FROM: abnormal intestinal epithelium morphology |
Mammalian Phenotype (MP) | abnormal professional antigen presenting cell physiology | 0.1418 | 1.098 | Moderately Informative | INHERITED FROM: decreased B cell proliferation |
Mammalian Phenotype (MP) | abnormal skin morphology | 0.1589 | 1.188 | Moderately Informative | INHERITED FROM: thick skin |
Mammalian Phenotype (MP) | abnormal lipid homeostasis | 0.1895 | 1.141 | Moderately Informative | INHERITED FROM: abnormal cholesterol homeostasis || abnormal sterol level || abnormal cholesterol level || abnormal circulating cholesterol level |
Mammalian Phenotype (MP) | abnormal myeloid cell morphology | 0.2623 | 0.9904 | Moderately Informative | INHERITED FROM: abnormal neutrophil cell number || abnormal phagocyte morphology |
Mammalian Phenotype (MP) | abnormal blood cell morphology | 0.3768 | 0.9129 | Moderately Informative | INHERITED FROM: abnormal neutrophil cell number |
Mammalian Phenotype (MP) | abnormal leukocyte physiology | 0.513 | 0.9219 | Moderately Informative | INHERITED FROM: decreased B cell proliferation || abnormal lymphocyte physiology |
Mammalian Phenotype (MP) | abnormal CD8-positive, alpha beta T cell morphology | 0.0000009119 | 1.7 | Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal CD4-positive, alpha beta T cell morphology | 0.000004172 | 1.562 | Informative | DIRECT |
Mammalian Phenotype (MP) | decreased cell proliferation | 0.000004713 | 1.603 | Informative | DIRECT |
Mammalian Phenotype (MP) | embryonic lethality prior to organogenesis | 0.00002109 | 1.457 | Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal embryonic growth/weight/body size | 0.000228 | 1.489 | Informative | DIRECT |
Mammalian Phenotype (MP) | postnatal growth retardation | 0.0003037 | 1.524 | Informative | DIRECT |
Mammalian Phenotype (MP) | premature death | 0.000339 | 1.524 | Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal blood coagulation | 0.0004826 | 1.399 | Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal cholesterol homeostasis | 0.0008343 | 1.524 | Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal sterol level | 0.0008441 | 1.489 | Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal renal glomerulus morphology | 0.0009908 | 1.457 | Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal B cell proliferation | 0.001272 | 1.562 | Informative | INHERITED FROM: decreased B cell proliferation |
Mammalian Phenotype (MP) | abnormal intestine morphology | 0.004002 | 1.457 | Informative | INHERITED FROM: abnormal intestinal epithelium morphology |
Mammalian Phenotype (MP) | abnormal thymus morphology | 0.01357 | 1.399 | Informative | INHERITED FROM: small thymus |
Mammalian Phenotype (MP) | abnormal granulocyte morphology | 0.01442 | 1.7 | Informative | INHERITED FROM: abnormal neutrophil cell number |
Mammalian Phenotype (MP) | abnormal alpha-beta T cell number | 0.06497 | 1.562 | Informative | INHERITED FROM: abnormal CD4-positive, alpha beta T cell number || abnormal CD8-positive, alpha-beta T cell number |
Mammalian Phenotype (MP) | abnormal lymph organ size | 0.1876 | 1.399 | Informative | INHERITED FROM: small thymus |
Mammalian Phenotype (MP) | abnormal glycogen level | 0.00001848 | 2.126 | Highly Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal neutrophil cell number | 0.00009313 | 1.904 | Highly Informative | DIRECT |
Mammalian Phenotype (MP) | decreased B cell proliferation | 0.0002823 | 1.904 | Highly Informative | DIRECT |
Mammalian Phenotype (MP) | impaired glucose tolerance | 0.0008753 | 1.825 | Highly Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal lung size | 0.00139 | 2.126 | Highly Informative | INHERITED FROM: abnormal lung weight |
Mammalian Phenotype (MP) | abnormal thymus size | 0.1123 | 1.904 | Highly Informative | INHERITED FROM: small thymus |
Mammalian Phenotype (MP) | small liver | 0.2742 | 2.001 | Highly Informative | INHERITED FROM: decreased liver weight |